CASE REPORT
Giant metanephric adenoma, benign tumor with features of clinical and radiological malignancy
More details
Hide details
1
Department of Human Histology and Embryology, University of Warmia and Mazury in Olsztyn, Poland
2
Department of Physiotherapy, Jozef Rusiecki University College in Olsztyn, Poland
3
Department of Surgical Oncology, Ministry of Internal Affairs Hospital with Warmia and Mazury Oncology Centre, Olsztyn, Poland
4
Department of Oncology, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Poland
5
Department of Radiology, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Poland
6
Department of Pathomorphology, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Poland
Submission date: 2014-11-05
Acceptance date: 2015-04-09
Online publication date: 2015-05-11
Publication date: 2020-03-24
Corresponding author
Janusz Godlewski
Department of Human Histology and Embryology, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-900 Olsztyn, Poland. Tel.: +48 698 694 528.
Pol. Ann. Med. 2015;22(1):45-49
KEYWORDS
ABSTRACT
Introduction:
Metanephric adenoma (MA) is a rare benign neoplasm, accounting for 0.2% of adult renal epithelial neoplasms. This neoplasm mainly occurs in patients aged 50–60 years.
Aim:
The aim of this study was presentation of rare kidney tumor assessment to elaborate proper postoperative decisions and further patient's recommendation.
Material and methods:
The case of a 64-year-old woman with MA is presented. Radiological, intraoperative and pathomorphological evaluations of this neoplasm were performed and compared.
Results and discussion:
Primarily performed CT imaging analyzed this tumor as a malignant neoplasm; organ destruction and evident mass invasion in the calyx and kidney pelvis region were noticeable. Regardless of the initial radiological and clinical characteristic, postoperative pathomorphological analyses recognized the benign nature of this tumor; regularly located tubules and small cell regular outlook were observable. Attention was given to a solid
fibrous capsule, which separated neoplasm from the rest of the healthy kidney structure. The patient was not qualified for adjuvant therapy, based on the pathomorphological evaluation due to characteristic nature of the benign kidney tumor. Nevertheless, in view of the initial observations (radiological and clinical) and because cases of metastases in the course of MA are described in the literature, a further periodic follow-up was strongly suggested to the patient.
Conclusions:
The evaluation of neoplasm tumor requires many analyses. In this rare tumor lack of correlation was observed between radiological and pathomorphological examinations. The clinical decision connected with the patient's recommendation should be based on complete results, especially pathomorphological diagnosis. The patient is now under clinical observation and in six months follow-up has had no neoplasm recurrence or metastasis.
CONFLICT OF INTEREST
All authors declare no conflict of interest.
REFERENCES (21)
1.
Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26(3):281–291.
2.
Burger M, Junker K, Denzinger S, et al. Metanephric adenoma of the kidney: a clinicopathological and molecular study of two cases. J Clin Pathol. 2007;60(7):832–833.
3.
Renshaw AA, Freyer RD, Hammers AY. Metastatic metanephric adenoma in a child. Am J Surg Pathol. 2000;24(4):570–574.
4.
Schmelz HU, Stoschek M, Schwerer M, et al. Metanephric adenoma of the kidney: case report and review of the literature. Int Urol Nephrol. 2005;37(2):213–217.
5.
Pins MR, Jones EC, Martul EV, Kamat BR, Umlas J, Renshaw AA. Metanephric adenoma-like tumors of the kidney: report of three malignancies with emphasis on discriminating features. Arch Pathol Lab Med. 1999;123(5):415–420.
6.
Nakagawa T, Kanai Y, Fujimoto H, et al. Malignant mixed epithelial and stromal tumors of the kidney: a report of the first two cases with a fatal clinical outcome. Histopathology. 2004;44(3):302–304.
7.
Sacco E, Pinto F, Totaro A, et al. Imaging of renal cell carcinoma: state of the art and recent advances. Urol Int. 2011;86(2):125–139.
8.
Kang SK, Chandarana H. Contemporary imaging of the renal mass. Urol Clin North Am. 2012;39(2):161–170.
9.
Heidenreich A, Ravery V. Preoperative imaging in renal cell cancer. World J Urol. 2004;22(5):307–315.
10.
Davis Jr CJ, Barton JH, Sesterhenn IA, Mostofi FK. Metanephric adenoma. Clinicopathological study of fifty patients. Am J Surg Pathol. 1995;19(10):1101–1114.
11.
Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt 1):2217–2220.
12.
Chaudhary H, Raghvendran M, Dubey D, et al. Correlation of radiological and clinical features of metanephric neoplasms in adults. Indian J Cancer. 2004;41(1):37–40.
13.
Fielding JR, Visweswaran A, Silverman SG, Granter SR, Renshaw AA. CT and ultrasound features of metanephric adenoma in adults with pathologic correlation. J Comput Assist Tomogr. 1999;23(3):441–444.
14.
Van Poppel H, Becker F, Cadeddu JA, et al. Treatment of localised renal cell carcinoma. Eur Urol. 2011;60(4):662–672.
15.
Volpe A, Cadeddu JA, Cestari A, et al. Contemporary management of small renal masses. Eur Urol. 2011;60(3):501–515.
16.
Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology. 2008;249(1):16–31.
17.
Kuroda N, Toi M, Hiroi M, Enzan H. Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol. 2003;18(1):253–257.
19.
Kwiatkowski P, Godlewski J, Śliwińska-Jewsiewicka A, Kmieć Z. The role of matrix metaloproteinases in tumor invasion. Pol Ann Med. 2008;15(1):66–76.
20.
Kuroda N, Tanaka A, Ohe C, Nagashima Y. Recent advances of immunohistochemistry for diagnosis of renal tumors. Pathol Int. 2013;63(8):381–390.
21.
Olgac S, Hutchinson B, Tickoo SK, Reuter VE. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod Pathol. 2006;19(2):218–224.